-
Market Wrap: Citi Trounces Q2 Expectations; Merger Monday; Drug Stocks Active on Results
-
Pre-Open Stock Movers 07/14: (PGNX) (KNDI) (URS) Higher; (HLIT) (RVBD) (GTAT) Lower (more...)
-
Pre-Open Stock Movers 1/29: (VRNG) (FSL) (DOW) Higher; (PGNX) (TUP) (BA) Lower (more...)
-
Notable Analyst Rating Changes 07/08: (BBRY) (LINE) (PGNX) Upgraded; (SSRI) (BSX) (INTC) Downgraded
-
StreetInsider.com Pre-Open Movers 5/10: (EAC) (CRIS) (GPS) Higher; (PTIE) (DRRX) (AFFY) Lower (more...)
-
Trading Radar for 03/15: Carnival (CCL), Brown Shoe (BWS), Federal Signal (FSS), Zogenix (ZGNX) Report
-
Citi Maintains 'Hold' Rating on Progenics Pharmaceuticals (PGNX), Increases Price Target
-
Pre-Open Movers 2/25:Progenics Pharma (PGNX) Jumps On FDA Approval, Netgear (NTGR) Down on Results
-
Citi Upgrades Progenics Pharmaceuticals (PGNX) to Hold
-
Citi Downgrades Progenics Pharmaceuticals (PGNX) to Sell

